We Are Excited to Be in the Consortium Kicking Off MELLODDY

The new research consortium seeks to accelerate drug discovery using machine learning to unlock maximum potential of pharma industry data. The project aims to leverage the world’s largest collection of small molecules with known biochemical or cellular activity to enable more accurate predictive models and increase efficiencies in drug discovery.

This is a companion discussion topic for the original entry at https://www.kubermatic.com/blog/2019-06-03-melloddy/